Anaemia gyermekkorban Molnár Dénes Gyermekklinika.

Az előadások a következő témára: "Anaemia gyermekkorban Molnár Dénes Gyermekklinika."— Előadás másolata:

1 Anaemia gyermekkorban Molnár Dénes Gyermekklinika

2 Cél Anaemia okainak áttekintése Anaemia diagnózisának felállításának megközelítése Vashiányos anaemia diagnosisa és kezelése Rövid tárgyalása a gyermekkori anaemiák egyéb okainak

3 A vörösvértest Élettartam: 120 days – 60-90 days in term & 35-50 days in preterm babies Termelődés –Regulated by epo (other hemopoietic factors. Colony- stimulating factors, interleukins, thrombopoietin are not mentioned here) Produced by kidneys in response to low O2 –Epo stimulates marrow to make RBC precursors –Needs iron, B12, folate, and amino acid Destrukció –When old or damaged, taken up by spleen

4 A vörösvértest Membrán Enzimek Hemoglobin –Heme (4 heme groups per Hb molecule) Mediates binding of O2 by Hb –Globin Protein that surrounds and protects heme molecule 2 alpha and 2 beta genes (adult Hb)

5

6 Fontosabb terminológia Hb –Vvt hb koncentrációja a vérben Ht (%) –A vér alakos elemeinek frakcionált volumene a vérben MCV –A vvt átlagos térfogata Microcyter, macrocyter, normocyter MCHC –Kalkulált érték (Hb/Ht) Alacsony MCHC hypochromiára utal

7 Fontosabb terminológia RDW ( Red Cell Distribution Width) –Vvt nagyságának variabilitását mutatja; normál értéke 11-15 Ferritin –Vas raktározott formája 1 ng ferritin: 10 mg raktározott vas Transferrin –Vas transzportját végzi Reticulociták –Fiatal vvt

8 Anaemia okai Csökkent produkció Fokozott destrukció Vérvesztés

9 Csökkent vvt termelés Defective heme synthesis –Iron deficiency, anemia of chronic disease, lead poisoning Defective globin synthesis –Alpha and beta thalassemia Defective DNA synthesis –Nutrient deficiencies (B12, folate) Impaired epo production –Renal disease

10 Csökkent vvt termelés Marrow failure –Aplastic anemia congenital Fanconi anemia is an autosomal recessive disorder affecting all bone marrow elements and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. (congenital) acquired –Red cell aplasia Congenital (Diamond-Blackfan) Acquired (Transient erythroblastopenia of childhood) Marrow replacement –Malignancy, myelofibrosis

11 Fokozódó destrukció Extracellular –Antibody mediated –Microangiopathic; HUS, DIC –Drugs, toxins –Hypersplenism

12 Fokozott pusztulás Intracelluláris –RBC membrán defektusok HS (hereditary spherocytosis, stomatocytosis [For as yet unknown reasons, the cells take on an abnormal shape, resembling a mouth or 'stoma‘]), HE (hereditary eliptocytosis) –Enzim defektusok PK (pyruvate kinase), G6PD –Hemglobinopathiák Sickle cell, thalassemia

13 Vérvesztés Akut vérzés Krónikus vérvesztés

14 Anaemia Definíció –Hb concentráció > 2 SD a normál populációs átlag alatt Normál értékek korral változnak

15 Életkori változások ÉletkorÚjszülött2 hetes3 hónapos6hó – 6 év7-12 év Hb (g/l)168 (137-210) 165 (130-200) 120 (95-145) 120 (105-140) 130 (110-160) Hct (%)55 (45-65)50 (42-66)36 (31-41)37 (33-42)38 (34-40) MCV (fl) lowest 11070-7476-80 Reticuloc ytes (%) 51111

16 Physiologiás anaemia Hb csökkenés 3 hónapos kor környékén Háttérben zajló fiziológiás változások –At birth, O2 sat rises sharply 65% in utero, nearly 100% when comes out –Decrease in epo production –Fetal RBC have shorter survival time (60 days)

17 Anaemia diagnózisa Anamnézis Fizikális vizsgálat Labor és egyéb vizsgálatok

18 Anamnézis Anyai anamnézis –Anaemia terhesség alatt –Terhesség és szülés Családi anamnézis –Etnikai hovatartozás –Anaemia –Sárgaság, epekőbetegség, cholecystectomia –Transfusio –Splenomegalia

19 Anamnézis Páciens –Sárgaság születés utáni időszakban –Diétás szokások –Gyógyszerszedés –Infekciók a közelmúltban –Krónikus betegségek –Bőrvérzések, vérzések –Pica

20 Fizikális vizsgálat General appearance –Pallor, jaundice, bruising Head and neck –Pale mucous membranes and conjunctiva –Angular stomatitis –Adenopathy Cardiac –Tachycardia, heart failure if severe –Heart murmur Abdomen –Organomegaly

21 Laborvizsgálatok Most often incidental finding CBC and smear –Hb, WBC, plt –MCV Reticulocyte count Depending on suspected process –Ferritin and iron studies, folate and B12, LDH, bili, Coombs, osmotic fragility, sickle screen, electrophoresis, bone marrow aspiration, renal function, liver function, etc

22 Morphológiai osztályozás Vvt nagyság szerint –Microcyter –Macrocyter –Normocyter

23 Microcyter anaemia Low MCV Small cells Etiologies –Iron-deficiency –Thalassemia –Chronic disease –Lead poisoning

24 Macrocyter anaemia High MCV Big cells Etiologies –Folic acid and B12 deficiency –Hypothyroidism –Chronic liver disease –Aplastic anemias

25 Normocyter Anaemia Normal MCV Production, destruction or loss Must look at reticulocyte count –Young RBC –Determines adequacy of bone marrow response

26 Normocyter anaemia High retic count –Blood loss –Hemolysis Low retic or normal count –Aplastic anemia –Leukemia –Chronic disease –TEC –Congenital hypoplastic syndromes

27 Vashiányos anaemia Epidemiology –Most common heme abnormality of childhood –Most common nutritional deficiency worldwide –500 million to 2 billion people are iron- deficient according to WHO 80% of world’s population

28 Vas metabolismus Body iron content: 2 to 6 g (2 g in adult female, 6 g in adult male) –1.5-2 g in Hb –0.5-1 g bound to enzymes, transferrin (protein that carries iron), in storage form (hemosiderin and ferritin) –The rest in myoglobin –At birth, most term infants have 75 mg of elemental iron per kilogram of body weight, found primarily as hemoglobin (75%), but also as storage (15%) and tissue protein iron (10%). Most iron is recycled Gut absorption depends on: –Epo production –Body iron stores –Bioavailability of dietary iron

29 Vas források Bioavailability factors –Fish, poultry, meat Iron 30% bioavailable –Vegetables Iron 10% bioavailable Absorbtion factors –Vitamin C increases absorbtion –Phytates (bran, oats, rye, fiber) and tea decrease absorbtion

30 Vasszükséglet Érett újszülött becsült napi vasszükséglete: 1 mg/kg A vasraktárak több mint 80%-a az utolsó trimesterben raktározódik. A koraszülöttek vasigénye ezért posztnatalisan fokozott. Koraszülöttek napi vasigénye: –1500 – 2500 gr – 2mg/kg/nap –< 1500 g – 4 mg/kg/nap Koraszülöttek igénye erythropoietin kezelés esetében - 6 mg/kg/nap

31 Vas felszívódás Generally 10% of dietrary iron is absobed Greater than 50% of iron from human milk is absorbed compared with typically less than 12% of iron from cow milk-derived formula

32 Rizikócsoportok Babies –Newborn body contains 75mg/kg –Infants triple blood volume in 1 st year –Each kg gain requires increase of 35 to 45 mg body iron –Term babies usually iron replete for 5-6 months, then need iron-fortified foods Iron recycled in first 2 to 3 months –Pre term at greater risk

33 Rizikócsoportok Toddlers –Too much cow’s milk!!! Maximum 16 oz/day Interferes with absorption from other food Colitis Decreased appetite for food Teenagers –Increased requirement due to growth spurt –Menstrual loss

34 Vashiány okai Newborn factors –LBW, perinatal hemorrhage, prematurity Dietary deficiencies –Insufficient intake, poor iron bioavailability Early cow’s milk exposure –Excessive cow’s milk intake Blood loss Iron deficiency itself! –Blunting of intestinal villi leads to increased blood loss

35 Lab eltérések Bone marrow hemosiderin first disappears –Most reliable indicator of tissue stores  RDW earliest sign on blood work  Ferritin  Iron,  TIBC  Hb Smear –microcytosis and hypochromia Retic normal or moderately increased –Insufficient response

36

37 Vashiány hosszútávú következményei Has been linked to ADHD and breath-holding spells –Although not well substantiated Exercise intolerance –Study done in teenagers Neurological impairment –More school difficulties, especially math and memory skills Increases lead absorption –Leading to more cognitive abnormalities

38 Szűrés 9 hónaposan ha rizikócsoportba tartozik –Canadian Task force ajánlása Magas rizikó –Kora- vagy sorvadt újsz. –Magas prevalenciájú közösségekben –Alacsony szociális helyzet –Speciális igényű páciensek Szűrés megfontolandó –Kisdedeknél hiányos diétával –Serdülők

39 Prevenció Anyatejes csecsemő –> 2 adag vasban gazdagított cerealia 6 hónapos kortól Tápszeres csecsemő –Vassal szupplementált formula alkalmazása Koraszülött anyatejes –Vas 1 to 2 mg/kg 1-6-12 hónapig 12 hónapos korig nincs tehéntej Tehéntej fogyasztásának limitálása kisdedeknél –< 500 ml 1-5 év között

40 Kezelés Diéta módosítás –Decrease cow’s milk –Increase iron-rich foods Vas terápia –4 to 6 mg/kg of elemental iron Increased absorption with Vit C

41 Kezelés Parenteral iron –2-3% anaphylaxis –No advantage PRBC transfusion –RARELY necessary –Only if hemodynamically unstable –3 to 5 cc/kg at a time, watch for CHF

42 Kezelésre adott válasz 12-24 hours –Intracellular replaced –Subjective improvement –Increased appetite 36-48 hours –Bone marrow response –Erythroid hyperplasia 48 to 72 hours –Retics increased, peak at around 5 to 7 days

43 Kezelésre adott válasz 4 to 30 days –Increased Hemoglobin 1 to 3 months –Repletion of iron stores Treat for a total of at least 3 months

44 Sikertelen kezelés Rossz compliance –10% GI mellékhatások –Rossz íz Folyamatos vérvesztés Rossz diagzózis

45

46 Különböző anaemiák jellemzői Parameterek, indexek Apl. Anaemia Folate, B12 def. Fe def.HemolysisVérvesztés MCV Hgb conc RBC Hgb conc Rets Se Bil

47 Mikor forduljunk gyermek hematológushoz? Neutropaenia és/vagy thrombocytopaenia Jelentős adenopathia/organomegalia Haemolysis gyanuja Hemodynamikai instabilitás és/vagy HCT < 20% Thalassemia major vagy sarlósejtes anaemia gyanuja Sikertelen vas szubsztitució esetén

48 Hereditary spherocytosis Prevalence: 1/5000 Etiology: Autosomal dominant, 25% have no previous family history Most common molecular defects: spectrin, ankyrin

49 Clinical manifestations Hyperbilirubinemia in the neonate Some children stay symptomeless until adulthood, others have recurrent hemolytic crisis After infancy the spleen is enlarged Gallstone Icterus

50 Treatment Transfusion Splenectomy

51 Diamond-Blackfan anemia Diamond-Blackfan anemia (DBA), also known as Blackfan–Diamond anemia and Inherited erythroblastopenia, is a congenital erythroid aplasia that usually presents in infancy. DBA patients have low red blood cell counts (anemia). The rest of their blood cells (the platelets and the white blood cells) are normal. This is in contrast to Schwachman-Diamond syndrome, in which the bone marrow defect results primarily in neutropenia, and Fanconi anemia, where all cell lines are affected resulting in pancytopenia.congenitalerythroidaplasiainfancy red blood cellanemiaplateletswhite blood cellsSchwachman-Diamond syndromebone marrowneutropeniaFanconi anemiapancytopenia

52 Clinical picture Diamond-Blackfan anemia is characterized by anemia (low red blood cell counts) with decreased erythroid in the bone marrow. This usually develops during the neonatal period. About 47% of affected individuals also have a variety of congenital abnormalities, including craniofacial malformations, thumb or upper limb abnormalities, cardiac defects, urogenital malformations, and cleft palate. Low birth weight and generalized growth delay are sometimes observed. DBA patients have a modest risk of developing leukemia and other malignanciesanemiared blood cellbone marrow neonatalcongenital craniofacialurogenitalcleft palateleukemia

53 Diagnosis Typically, a diagnosis of DBA is made through a simple blood count and a bone marrow biopsy.blood countbone marrow biopsy A diagnosis of DBA is made on the basis of anemia, low reticulocyte (immature red blood cells) counts, and diminished erythroid precursors in bone marrow. Features that support a diagnosis of DBA include the presence of congenital abnormalities, macrocytosis, elevated fetal hemoglobin, and elevated adenosine deaminase levels in red blood cells.reticulocyte macrocytosisfetal hemoglobinadenosine deaminase Most patients are diagnosed in the first two years of life. However, some mildly affected individuals only receive attention after a more severely affected family member is identified. About 20-25% of DBA patients may be identified with a genetic test for mutations in the RPS19 gene.(19q13.2)genetic testRPS19

54 Treatment Corticosteroid Transfusion Bown marrow transplantation

55 Transient erythroblastopenia of childhood (TEC) Acquired erythroid bone marrow failure –Unknown etiology 18 mos to 2 yrs Often follows viral illness Child otherwise healthy Resolves spontaneously –Weeks to months

56 TEC Lab findings –Normocytic anemia (Hb 50-70, sometimes as low as 20) –Low retic count –No evidence of hemolysis –Other cell lines unaffected Treatment –Supportive –Transfusion if symptomatic

57 Hemoglobinopathies Thalassemia –Decreased or absence of production of one or more globin chains Alpha, beta, and variants Sickle cell disease –Structural defect of beta-globin chain

58 Thalassemia Epidemiology –Prevalent in certain populations Africa, Middle East, Asia, and Mediterranean population Pathogenesis –Decreased or absent synthesis of one or more globin chains Imbalance in number of chains –Precipitation of unstable Hb Hemolysis occurs

59 Alpha-Thalassemia Common in Asian and black populations Phenotype depends on number of deletions –1-gene deletion Silent carrier, no anemia –2-gene deletion (trait) Mild hypochromic, microcytic anemia –3-gene deletion (Hemoglobin H) Severe anemia Hb Bart (gamma globin tetramers) –4-gene deletion Incompatible with life Hb Bart

60 Beta-thalassemia Mediterranean or Southeast Asian origin Phenotype depends on number and type of mutations –Minor Microcytic anemia –Intermedia Moderate to severe anemia –Major Severe anemia, transfusion dependant

61 Diagnosis Family history, ethnic origin CBC –Microcytic anemia Normal or increased ferritin Hb electrophoresis –Decreased HbA, increased HbF –Abnormal Hemoglobins Gene studies

62 Treatment Alpha trait –None –Counseling Severe anemia –Transfusion –Watch for iron overload –Chelation therapy –Splenectomy

63 Sickle Cell Disease Defect of beta-globin chain –Amino acid substitution (valine for glutamine) Prevalent in certain populations –African, Caribbean, Middle Eastern, Indian, Mediterranean populations Hb susceptible to deoxygenation, acidosis, temperature, dehydration –RBC distorted into sickle shape –Results in tissue ischemia and infarction –Shortened RBC survival

64 Sickle Cell Disease Manifestations (only in disease, not if trait) –Bony crisis –Chest crisis –Strokes –Splenic sequestration –Aplastic anemia Susceptibility to infections; autosplenectomize –Encapsulated organisms Need penicillin prophylaxis

65 Treatment Pain control –NSAIDs, opiates Hydration Antibiotics if febrile Transfusions Exchange transfusions Hydroxyurea